These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 828757)

  • 1. [The "in vitro" susceptibility of pseudomonas aeruginosa to tobramycin (author's transl)].
    Fernández H; Otth L
    Rev Med Chil; 1976 Jul; 104(7):473-4. PubMed ID: 828757
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kinetics of bactericidial function of cefotaxim against Pseudomonas aeruginosa alone and in combination with tobramycin].
    Shah PM; Troche G; Stille W
    Med Welt; 1980 Aug; 31(35):1244-5. PubMed ID: 6252415
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 4. [In vitro studies of tobramycin sensitivity of bacterial strains isolated from children treated in the Institute for Mother and Child].
    Duroś H; Nowakowska K
    Probl Med Wieku Rozwoj; 1982; 11():117-20. PubMed ID: 6817325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro effects of the combination of carbenicillin with gentamicin or tobramycin with respect to Pseudomonas aeruginosa].
    Turgeon PL; Croteau L
    Union Med Can; 1977 May; 106(5):682-5. PubMed ID: 405784
    [No Abstract]   [Full Text] [Related]  

  • 6. [The "in vitro" sensitivity of pseudomonas aeruginosa to antibiotic and chemotherapeutic agents (author's transl)].
    Paredes L; Valenzuela E; Caorsi B; Castillo M
    Rev Med Chil; 1976 Sep; 104(9):615-9. PubMed ID: 828758
    [No Abstract]   [Full Text] [Related]  

  • 7. Routine susceptibility tests with ticarcillin and tobramycin in combination should be more appropriate than with each antibiotic alone in cystic fibrosis Pseudomonas aeruginosa.
    Lapointe JR; Bourget C; Mainville S; Lafleur L; Lagacé J; Montplaisir S
    J Chemother; 1989 Jul; 1(4 Suppl):184-6. PubMed ID: 16312360
    [No Abstract]   [Full Text] [Related]  

  • 8. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment.
    MacLeod DL; Nelson LE; Shawar RM; Lin BB; Lockwood LG; Dirk JE; Miller GH; Burns JL; Garber RL
    J Infect Dis; 2000 Mar; 181(3):1180-4. PubMed ID: 10720551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In-vitro effect of tobramycin].
    Jedlicková Z
    Z Arztl Fortbild (Jena); 1977 Jul; 71(13):651-2. PubMed ID: 412333
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of inhibitory (MIC) and subinhibitory concentrations of tobramycin on bacteriostatic and bactericidal activities of beta-lactam antibiotics (author's transl)].
    Masuda G; Yajima T; Nakamura K; Yanagishita T; Yamazaki E
    Jpn J Antibiot; 1979 Nov; 32(11):1189-95. PubMed ID: 117156
    [No Abstract]   [Full Text] [Related]  

  • 11. A study of cefoperazone alone and in combination with tobramycin against Pseudomonas aeruginosa.
    Pavillard ER; Miles H
    Clin Ther; 1980; 3(Spec Issue):134-8. PubMed ID: 6446387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticarcillin-tobramycin-rifampin: in vitro synergy of the triplet combination against Pseudomonas aeruginosa.
    Zuravleff JJ; Yu VL; Yee RB
    J Lab Clin Med; 1983 Jun; 101(6):896-902. PubMed ID: 6406628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa.
    Schurek KN; Marr AK; Taylor PK; Wiegand I; Semenec L; Khaira BK; Hancock RE
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4213-9. PubMed ID: 18824604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro bactericidal activity of allicin combined with cefoperazone, tobramycin and ciprofloxacin.
    Cai Y; Wang R; An MM; Liang BB; Fang Y
    Int J Antimicrob Agents; 2008 Feb; 31(2):179-80. PubMed ID: 18083012
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis.
    Burns JL; Van Dalfsen JM; Shawar RM; Otto KL; Garber RL; Quan JM; Montgomery AB; Albers GM; Ramsey BW; Smith AL
    J Infect Dis; 1999 May; 179(5):1190-6. PubMed ID: 10191222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sensitivity to antibiotics of Pseudomonas aeruginosa isolated from patients in the years 1986-1988].
    Gościniak G; Dolna I; Ruczkowska J; Fleischer M
    Wiad Lek; 1989 Oct 1-Nov 1; 42(19-21):1028-32. PubMed ID: 2517806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pseudomonas: microbiological aspects and sensitivity to tobramycin and gentamycin].
    Ceruti T; Bassi L; Biazzi E; Fasani AM; Pedroni P
    Arch Sci Med (Torino); 1982; 139(4):463-5. PubMed ID: 6820271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possible use of pyocins against Pseudomonas aeruginosa (author's transl)].
    Sezen IY; Blobel H; Scharmann W
    Zentralbl Bakteriol Orig A; 1974; 229(2):205-8. PubMed ID: 4155865
    [No Abstract]   [Full Text] [Related]  

  • 19. [In vitro behavior of Pseudomonas, Serratia and Acinetobacter towards tobramycin].
    Denis F
    Nouv Presse Med; 1974 Apr; 3(0):48-51. PubMed ID: 4209338
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tobramycin, a new aminoglycoside antibiotic].
    Periti P; Serra E
    G Ital Chemioter; 1973; 20(1-4):15-9. PubMed ID: 4156968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.